BCL2 and diffuse large B-cell lymphoma: Indeed, apoptosis might be targeted with selective BCL-2 inhibitors such as venetoclax (ABT199) when added to R-CHOP [235], and is being further explored in combination with anti-PD-1 and anti-CD20 in R/R DLBCL (NCT03276468) [236].